Your session is about to expire
← Back to Search
Brain Stimulation for Improved Walking in Aging
Phase < 1
Recruiting
Led By David J. Clark, DSc
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age 65 years or older
Preferred 10m walking speed < 1.1 m/s
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured at follow up visit (approximately three weeks after baseline)
Awards & highlights
Study Summary
This trial will investigate whether non-invasive brain stimulation can help improve walking ability in older adults by enhancing motor learning.
Who is the study for?
This trial is for adults aged 65 or older who have some difficulty with walking tasks, like getting tired easily while walking or climbing stairs. They should be able to walk at a speed less than 1.1 meters per second and must not be currently enrolled in any other clinical trials or physical therapy for lower extremity function.Check my eligibility
What is being tested?
The study tests whether brain stimulation (tDCS) can help improve motor learning and retention of complex walking skills in older adults. Participants will practice a complex walking task and receive either Dosage A or B of tDCS, randomly assigned.See study design
What are the potential side effects?
Potential side effects from transcranial direct current stimulation may include mild tingling, itching, burning sensation on the scalp, fatigue, headache, nausea or discomfort during the procedure.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 65 years old or older.
Select...
I walk slower than 1.1 meters per second.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ measured at follow up visit (approximately three weeks after baseline)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured at follow up visit (approximately three weeks after baseline)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Walking speed change from baseline
Secondary outcome measures
Brain resting state network segregation
Prefrontal cortex gray matter volume change from baseline
Trial Design
2Treatment groups
Experimental Treatment
Group I: tDCS Dosage BExperimental Treatment2 Interventions
mild electrical stimulation (Dosage level "B") delivered to the frontal region of the brain during practice of a complex walking task
Group II: tDCS Dosage AExperimental Treatment2 Interventions
mild electrical stimulation (Dosage level "A") delivered to the frontal region of the brain during practice of a complex walking task
Find a Location
Who is running the clinical trial?
VA Office of Research and DevelopmentLead Sponsor
1,611 Previous Clinical Trials
3,305,224 Total Patients Enrolled
23 Trials studying Aging
2,759 Patients Enrolled for Aging
David J. Clark, DScPrincipal InvestigatorNorth Florida/South Georgia Veterans Health System, Gainesville, FL
3 Previous Clinical Trials
131 Total Patients Enrolled
1 Trials studying Aging
23 Patients Enrolled for Aging
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have trouble communicating in English or with the study team.I do not have serious heart, lung, kidney diseases, diabetes, or a terminal illness.I have had a bone fracture or joint replacement in the last 6 months.I am taking medication that affects my brain function.I have been diagnosed with schizophrenia, bipolar disorder, or another psychotic disorder.I do not have metal in my head or wounds on my scalp.I am currently in physical therapy for my legs or undergoing heart/lung rehab.I have not had a heart attack or major heart surgery in the last year.I haven't had cancer treatment in the past year, except for minor skin cancers or early stage breast/prostate cancer.I have a diagnosed brain condition like Alzheimer's, Parkinson's, or had a stroke.I have severe arthritis and am waiting for a joint replacement.My blood pressure is not higher than 180/100 mmHg.I am 65 years old or older.I walk slower than 1.1 meters per second.My BMI is over 35, indicating severe obesity.I get tired from walking a short distance or climbing stairs.
Research Study Groups:
This trial has the following groups:- Group 1: tDCS Dosage B
- Group 2: tDCS Dosage A
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is the enrollment process for this research still open?
"Per clinicaltrials.gov, this medical experiment is actively seeking volunteers to participate; the trial first went online August 1st 2019 and was last updated April 7th 2022."
Answered by AI
To what extent is the study population being augmented through patient enrolment?
"Correct. Evidence hosted on clinicaltrials.gov attests to this medical trial being actively recruiting as of April 7th, 2022; it was initially uploaded onto the website on August 1st 2019 and requires 60 participants from a single location."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger